Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New endoscopic procedure aims to help people with obesity lose weight

NCT ID NCT05713071

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new procedure called BEAM (Bariatric Endoscopic Antral Myotomy) to help people with obesity lose weight. The procedure uses a tube down the throat to make small cuts in the stomach muscle, aiming to change how the stomach empties. Twenty adults with a BMI between 30 and 50 will be followed for a year to see if it is safe and helps with weight loss.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Bariatric Endoscopic Antral Myotomy (BEAM) procedure
What this could lead to
If successful, BEAM could offer a less invasive weight-loss option for people with obesity, potentially reducing the need for more major surgery.
What could go wrong
This is a very small pilot study with only 20 people, so results may not apply broadly. The procedure is new and long-term safety and effectiveness are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

20 people

The number who actually took part.

Started

Feb 2024

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Subjects must be 18-70 years of age 2. Are currently in the CWMW lifestyle modification program 3. Have a diagnostic endoscopy approved for bariatric evaluation 4. Eligible for endoscopic and surgical weight loss procedures 5. Body mass index (BMI) 30-50 kg/m2 6. Individuals must be in excellent mental health 7. Able to understand and sign informed consent 8. Available to return for all routine follow-up study visits Exclusion Criteria: 1. Untreated H. pylori infection 2. Active smoking 3. Ongoing or a history of treatment with opioids in the last 12 months prior to enrollment 4. Previous pyloromyotomy or pyloroplasty 5. Gastrointestinal obstruction 6. Severe coagulopathy 7. Esophageal or gastric varices and/or portal hypertensive gastropathy 8. Pregnancy or puerperium 9. Any inflammatory disease of the gastrointestinal tract (including but not limited to severe (LA Grade C or D) esophagitis, active gastric ulceration, active duodenal ulceration, or specific inflammation such as Crohn's disease) 10. Malignant or premalignant gastric diseases (such as high grade dysplasia, gastric cancer, or GIST) 11. Severe cardiopulmonary disease or a history of coronary artery disease (including myocardial infarction within the past 6 months, poorly controlled hypertension, required use of NSAIDs) 12. Lactation 13. History of gastrointestinal surgery 14. Any serious health condition unrelated to their weight that would increase the risk of endoscopy 15. Chronic abdominal pain 16. Active psychological issues preventing participation in a lifestyle modification program 17. A known history of endocrine disorders affecting weight (uncontrolled hypothyroidism) 18. An inability to provide informed consent 19. Use of any medication that may interfere with weight loss 20. Use of any medication that may interfere with gastric emptying 21. Any other condition which the investigator may deem as an impediment to compliance or hinder completion of the proposed study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Delayed gastric emptying following procedure are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Brigham and Women's Hospital

    Boston, Massachusetts, 02115, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.